title: Increased serum concentrations of soluble HLA-class I antigens in hepatitis C virus related mixed cryoglobulinaemia.
abstract: OBJECTIVE
  To investigate whether quantitative alterations of both beta(2)microglobulin (beta(2)micro) associated HLA class I heavy chains (sHLA-I) and beta(2) micro free class I heavy chains (sHLA-FHC) in sera of patients with hepatitis C virus (HCV) infection occur and whether they distinguish patients with mixed cryoglobulinaemia (MC).
  
  
  METHODS
  83 HCV infected patients were studied and divided into three groups: (A) without cryoglobulinaemia (n=21), (B) with polyclonal MC (n=20), (C) with monoclonal MC (n=42). Serum sHLA-I and sHLA-FHC were measured by double determinant radioimmunoassay using monoclonal antibodies: TP25.99 as catching antibody, and NAMB-1 and HC-10 as revealing antibodies. Western blot identified HLA-I isoforms.
  
  
  RESULTS
  The serum concentrations of sHLA-I and of sHLA-FHC in HCV infected patients versus controls were respectively 1.3(0.5) microg/ml (mean (SD)) versus 0.8 (0.3) (p<0. 001) and 13.9 (7.1) ng/ml versus 9.2 (5) (p<0.001). sHLA-I were 1.01 (0.4) microg/ml in group A, 1.04 (0.4) microg/ml in group B, and 1. 47 (0.4) microg/ml in group C (p=0.001). Statistical analysis showed a significant difference versus controls for groups B (p<0.02) and C (p<0.001). sHLA-FHC were 12.8 (8.3) ng/ml in group A, 17.2 (7.1) ng/ml in group B, and 12.9 (6.2) ng/ml in group C (p<0.02). A significant difference versus controls for each group was found (p<0. 02, p<0.001, and p<0.02, respectively). Different patterns of sHLA-I isoforms were observed.
  
  
  CONCLUSIONS
  Increased serum concentrations of sHLA-I and sHLA-FHC characterise HCV infected patients. The highest sHLA-I concentrations seem to distinguish patients with monoclonal MC. In this last condition sHLA could play a part in the HCV escape and in B cell proliferation. The significance of sHLA-FHC is still undefined.
authors.affiliation: Istituto di Clinica Medica, Reumatologia, Seconda Università degli Studi, Napoli, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Migliaresi
authors.forename: A
authors.initials: A
authors.lastname: Bresciani
authors.forename: L
authors.initials: L
authors.lastname: Ambrosone
authors.forename: M
authors.initials: M
authors.lastname: Spera
authors.forename: D
authors.initials: D
authors.lastname: Barbarulo
authors.forename: V
authors.initials: V
authors.lastname: Lombari
authors.forename: G
authors.initials: G
authors.lastname: Pirozzi
authors.forename: G
authors.initials: G
authors.lastname: Borgia
authors.forename: M L
authors.initials: ML
authors.lastname: Lombardi
authors.forename: G
authors.initials: G
authors.lastname: Tirri
authors.forename: C
authors.initials: C
authors.lastname: Manzo
mesh_terms: D000328:Adult; D000368:Aged; D015153:Blotting, Western; D003430:Cross-Sectional Studies; D003449:Cryoglobulinemia / Q000276:immunology* / Q000821:virology; D005260:Female; D006526:Hepatitis C / Q000150:complications / Q000276:immunology*; D015395:Histocompatibility Antigens Class I / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011863:Radioimmunoassay / Q000379:methods; D012995:Solubility
chemical_list: D015395:Histocompatibility Antigens Class I